A Study of Meditation as a Treatment for Epilepsy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2006 by University of California, Los Angeles.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT00370929
First received: August 30, 2006
Last updated: NA
Last verified: March 2006
History: No changes posted
  Purpose

Epileptic seizures may occur at times of stress and commonly increase life stress. This study will evaluate whether meditation improves seizure control and quality of life for individuals with uncontrolled epilepsy.


Condition Intervention Phase
Epilepsy
Behavioral: Meditation
Phase 2

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Treatment of Epilepsy by Meditation and Cultivation of Emotional Balance

Resource links provided by NLM:


Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:
  • Seizure frequency
  • Quality of Life

Secondary Outcome Measures:
  • Mood
  • Affect
  • Anxiety
  • Sleep quality

Estimated Enrollment: 8
Study Start Date: May 2006
Detailed Description:

Individuals who have uncontrolled epilepsy commonly experience disability, depression, anxiety and injuries from seizures. For such individuals, ideal treatments should improve quality of life through control of seizures and improved emotional state. Meditation with cultivation of emotional balance is known to improve emotional state and may also benefit seizure control in some individuals. In this study, individuals with uncontrolled epilepsy will receive detailed training in meditation to determine whether the training leads to improvements in seizure control and various measures of emotion and quality of life.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • 6 or more seizures per month
  • ability to participate in meditation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00370929

Locations
United States, California
Geffen School of Medicine at UCLA
Los Angeles, California, United States, 90095
Sponsors and Collaborators
University of California, Los Angeles
Investigators
Principal Investigator: John Stern, MD University of California, Los Angeles
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00370929     History of Changes
Other Study ID Numbers: HSPC-06-03-001
Study First Received: August 30, 2006
Last Updated: August 30, 2006
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Epilepsy
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases

ClinicalTrials.gov processed this record on July 26, 2014